Epclusa® (sofosbuvir and velpatasvir)
for Hepatitis C

Epclusa is a once-daily antiviral treatment for chronic hepatitis C in adults and children aged 3 and older. It contains sofosbuvir and velpatasvir, which work together to block the HCV NS5 protein, preventing the virus from multiplying in the body.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hepatitis C - Hep C